ImageneBio, Inc. (ticker: IMA) filed an 8-K on August 5, 2026, to announce its financial results for the quarter ended June 30, 2026. The press release is attached as Exhibit 99.1, but the filing does not restate any specific numbers, so the actual performance isn't visible in this excerpt.
View Full Filing (SEC EDGAR)